F5. CIRCULATING IGFBP-2 LEVELS REVEAL ATHEROGENIC METABOLIC RISK IN SCHIZOPHRENIC PATIENTS USING ATYPICAL ANTIPSYCHOTICS
Sign Up to like & getrecommendations! Published in 2019 at "Schizophrenia Bulletin"
DOI: 10.1093/schbul/sbz018.417
Abstract: Objectives: Second generation antipsychotics (SGAs) induce weight gain and dyslipidemia, albeit with important intervariability. Insulin-like growth factor binding protein (IGFBP)-2 is proposed as a circulating biomarker negatively associated with waist circumference and hypertriglyceridemia. Thus, we… read more here.
Keywords: igfbp levels; metabolic risk; risk schizophrenic; patients using ... See more keywords